{"nctId":"NCT03720899","briefTitle":"Comparing NicoBloc to Nicotine Lozenges","startDateStruct":{"date":"2019-03-21","type":"ACTUAL"},"conditions":["Smoking Cessation","Nicotine Dependence"],"count":45,"armGroups":[{"label":"NicoBloc","type":"EXPERIMENTAL","interventionNames":["Drug: NicoBloc"]},{"label":"Nicotine Lozenge","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Nicotine Lozenge"]}],"interventions":[{"name":"NicoBloc","otherNames":[]},{"name":"Nicotine Lozenge","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n1. 18 years or older\n2. planning to live in the Birmingham Metro area for the next 3 months\n3. Smoking at least 5 cigarettes per day for the past year and a Carbon Monoxide\\>8ppm to ensure daily smoking. This relatively low cutoff was chosen due to the expectation of enrolling a large \\>50% African-American average \\<10 cigarettes per day compared to Whites who average \\~15 cigarettes per day\n4. exclusive use of filtered cigarettes\n5. English speaking.\n\nExclusion Criteria:\n\n1. Living in a restricted environment that does not allow smoking (e.g., prison or jail facility, etc.)\n2. Pregnant or nursing (all women of childbearing potential will be required to use an acceptable form of contraception)\n3. Currently enrolled in a smoking cessation treatment program, using nicotine replacement products, or prescribed bupropion or varenicline\n4. Known allergy nicotine lozenge\n5. Within one month post-myocardial infarction or untreated severe angina\n6. Cognitive impairment or unstable psychiatric condition that interferes with the informed consent process (individuals stable on psychiatric medications will be included)\n7. Daily or exclusive use of other tobacco products (e.g., electronic cigarettes, little cigars, etc.).","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"The Treatment Satisfaction Survey","description":"* Number of items: 10\n* Scale: 1 (not at all helpful) - 7 (very helpful), as well as \"0\" response for \"Don't Know\".\n* Full-scale range: 0-70\n* Interpretation: Higher scores indicate more treatment satisfaction Subscales: N/A","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"63.62","spread":"7.04"},{"groupId":"OG001","value":"64.67","spread":"17.25"}]}]}]},{"type":"SECONDARY","title":"Change in the Questionnaire of Smoking Urges-Brief Form, From Baseline to Week 4 Timepoint","description":"* Number of items: 10\n* Scale: 1 (Strongly Disagree) - 7 (Strongly Agree)\n* Full-scale range: 10-70\n* Interpretation: Higher scores indicate more smoking urges Subscales: N/A","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-1.75","spread":"5.6"},{"groupId":"OG001","value":"-.65","spread":"5.06"}]}]}]},{"type":"SECONDARY","title":"Retention Rates","description":"The total number of participants retained throughout the entirety of the study duration.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"13","spread":null},{"groupId":"OG001","value":"13","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":21},"commonTop":[]}}}